SynBiotic SE

Recommendation

Buy

Price Target

€12.40

Upside

311.96%

Chart
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 3Y

€3.01

(€0.19) (-5.94%)
Realtime-Data from 28.04.2025 07:43:50
SYNBIOTIC is a Buy-and-Build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
Ticker
SBX GY
Market Cap
€16.85 M
Enterprise Value
€19.93 M
26 week avg vol.
13500
Primar Exchange
Xetra
IPO
2019
Sector
Health Care & Pharma
Headquarters
München, DE
Employees
55
Incorporated
2015
CEO
Daniel Kruse
CEO
7.62%
Other institutional investors
47.00%
Free Float
45.38%
20.09.2024
Annual General Meeting
30.09.2024
Publication half yearly financial report

KPIs in EUR

KPI20232024e2025e
Sales3.86 M15.92 M22.99 M
EBITDA(7.19 M)(1.01 M)1.84 M
EBIT(11.75 M)(2.13 M)756.62 K
EPS(2.12)(0.30)0.06
FCF(2.94 M)(4.33 M)1.35 M

Valuation

KPI20232024e2025e
EV / Sales5.16x1.23x0.80x
EV / EBITDA(2.77x)(19.38x)9.97x
EV / EBIT(1.70x)(9.23x)24.19x
Price / Earnings(1.42x)(9.89x)49.83x
EV / FCF(6.77x)(4.54x)13.53x

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.